Intralytix receives Phase II Fast Track NIH SBIR contract to continue development of a universal, scale-independent AI-based platform for manufacturing…
Super UserAugust 24, 2022
Dr. Amrie Grammer, co-founder of AMPEL BioSolutions, joins the show to discuss biotech and her company Hosted by Paul Sweeney…
Super UserAugust 22, 2022
After getting smallpox vaccine ACAM2000 from Sanofi and an anthrax treatment called raxibacumab from GlaxoSmithKline, Emergent BioSolutions is buying again,…
Super UserAugust 22, 2022
Congress has approved a new agency — the Advanced Research Projects Agency for Health (ARPA-H) — that will ‘supercharge’ breakthrough…
Super UserAugust 22, 2022
Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its $270 million deal for vaccine…
Super UserAugust 22, 2022
We just released 8 new high priority funding opportunities where your company can make a difference in meeting the needs…
Super UserAugust 19, 2022
SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today…
Super UserAugust 19, 2022
The Washington, D.C./Baltimore region continued to see a tightening in its life sciences real estate market. In particular, the region…
Super UserAugust 19, 2022
The fiscal year 2022 program is now closed. The fiscal year 2023 program will begin accepting applications as follows: Commerce…
Super UserAugust 19, 2022